• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    Sorrento Issues Supplement to its Previously Issued "FAQ" Regarding the Dividend of Scilex Holding Company Common Stock

    2/2/23 2:12:00 PM ET
    $SRNE
    Biotechnology: Commercial Physical & Biological Resarch
    Health Care
    Get the next $SRNE alert in real time by email

    SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento"))) today posted a supplement to its previously issued "Frequently Asked Questions" document under the "Investors" section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company held by Sorrento.

    The supplement to the FAQs provides notice regarding the Depository Trust and Clearing Corporation's removal of the contra-CUSIP on Scilex common stock that was distributed as a dividend to Sorrento's stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a dividend confirmation had previously been distributed to such firms by Scilex's transfer agent and requests that such firms contact Scilex's transfer agent if they have not received such confirmation. The supplement also reiterates a question related to issues that may arise with respect to the dividend in connection with short positions in Sorrento common stock.

    The supplement to the FAQs and related annex are included in this press release and can also be found here.

    SUPPLEMENT TO

    FREQUENTLY
    ASKED QUESTIONS 

    REGARDING THE DIVIDEND OF SCILEX HOLDING COMPANY COMMON STOCK BY

    SORRENTO THERAPEUTICS, INC.

    This supplement is a supplement to the Frequently Asked Questions Regarding the Dividend of Scilex Holding Company Common Stock by Sorrento Therapeutics, Inc. (Sorrento) that was issued by Sorrento on January 29, 2023 (the FAQ), a copy of which can be found under the "Investors" section of its website at www.sorrentotherapeutics.com. This supplement is being issued to update and supplement the information in the FAQ to notify investors regarding certain matters relating to the dividend and reiterate certain questions and answers from the FAQ. Capitalized terms used in this supplement shall have their respective meetings set forth in the FAQ.

    NOTICE OF REMOVAL OF CONTRA-CUSIP BY DTCC

    Effective as of February 2, 2023, the Depository Trust and Clearing Corporation has removed the "contra-CUSIP" that it had previously imposed on the Dividend Stock. Any shares of Dividend Stock held by your brokerage firm, bank, dealer or other similar organization for your benefit now bear only Scilex's CUSIP number, which is 80880W106. If you are entitled to receive Dividend Stock, please contact your brokerage firm, bank, or other similar organization immediately to confirm that the CUSIP number appears on your brokerage statement with respect to your Dividend Stock.

    NOTICE TO BROKERAGE FIRMS, BANKS, DEALERS AND OTHER SIMILAR ORGANIZATIONS

    If the name of your firm, bank or other similar organization is set forth on Annex B of the FAQ, which Annex B is repeated below for convenience, and your firm, bank or similar organization has not received the Dividend Confirmation that was mailed to your firm, bank or similar organization, please contact Scilex's transfer agent immediately to obtain a copy of the Dividend Confirmation. Please note that copies of the Dividend Confirmations mailed to the organizations set forth on Annex B are set forth on the Annex B-1. Scilex's transfer agent's contact information is as follows:

    Continental Stock Transfer & Trust Company

    Telephone Number
    : 800-509-5586 

    Email Address: [email protected]

    Several major brokers have confirmed to Sorrento and Scilex that they are adding the Scilex share positions to the individual brokerage accounts of Sorrento shareholders receiving the Dividend Stock.

    SUPPLEMENTAL QUESTION AND ANSWER

    Q:If I loaned my shares of Sorrento common stock to short sellers or any other party as of the Record Date, am I still entitled to receive Dividend Stock as of the Payment Date?
    A:Only Record Holders as of the Record Date are entitled to receive the Dividend Stock. If you were the Record Holder as of the Record Date and are entitled to receive the Dividend Stock, but have not received the Dividend Stock, you may be entitled to receive Dividend Stock from the short seller or other party who borrowed your shares of Sorrento common stock, whether through the lending programs implemented by your brokerage firm, bank, dealer and other similar organization or otherwise. If you were a Record Holder as of the Record Date and have not received your Dividend Stock, please consult with your financial advisor, broker or other agent immediately to determine how to receive your Dividend

    Stock.

    Annex B

    Broker
    List

    Broker NameBroker Address Broker NameBroker Address
    ABN AMRO CLEARING CHICAGO LLC175 WEST JACKSON BLVD. CHICAGO

    IL ILLINOIS 60604 US
    Albert Fried & Company LLC45 BROADWAY, 24TH FLOOR

    24TH FLOOR NEW YORK NY NEW YORK

    10006 US
    AMALGAMATED BANK275 7TH AVENUE NEW YORK

    NY NEW YORK 10003 US
    AMERICAN ENTERPRISE INVESTMENT SERVICES INC.682 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS

    MN MINNESOTA 55474 US



    Broker NameBroker Address Broker NameBroker Address
    APEX CLEARING CORPORATION2 GATEWAY

    CENTER 283-299 MARKET ST 16TH FLOOR NEWARK

    NJ NEW JERSEY 07102-5005 US
    BANK OF AMERICA, NA/GWIM TRUST OPERATIONS901 MAIN STREET

    12TH FLOOR DALLAS

    TX TEXAS 23113 US
    BANK OF NEW YORK MELLON111 SANDERS CREEK PARKWAY 2ND FLOOR

    2ND FLOOR EAST SYRACUSE NY NEW YORK 13057 US.
    BARCLAYS CAPITAL INC.DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS- MILLER OR ROBERT MENDEZ

    JERSEY CITY NJ NEW JERSEY

    07310 US
    BARCLAYS CAPITAL INC.DTC CUSTODY PARTICIPANT- NY WINDOW -570 WASHINGTON BLVD (ATTN: ROSA HICKS-MILLER OR ROBERT MENDEZ JERSEY CITY

    NJ NEW JERSEY 07310 US
    BMO CAPITAL MARKETS CORP.3 2ND STREET

    12TH FLOOR JERSEY CITY NJ NEW JERSEY 07302 US
    BMO HARRIS BANK NA/TRUST11270 W PARK PL MILWAUKEE

    WI WISCONSIN 53224 US
    BMO Nesbitt Burns Inc., Toronto250 YONGE STREET,

    7TH FLOOR

    7TH FLOOR TORONTO ON ONTARIO M5B 2M8 CA

    CANADA
    BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME

    BROKERAGE CUSTODIAN
    100 WEST 33RD STREET

    3RD FLOOR NEW YORK NY NEW YORK

    10001
    BNP PARIBAS, NEW YORK BRANCH/BNP PARIBAS PRIME

    BROKERAGE CUSTODIAN
    100 WEST 33RD STREET

    3RD FLOOR NEW YORK NY NEW YORK

    10001
    BNY MELLONPO BOX 392002

    500 ROSS STREET PITTSBURGH

    PA

    PENNSYLVANIA 15262 US
    BNY MELLON/WEALTH MANAGEMENT1 FREEDOM VALLEY DRIVE

    OAKS

    PA PENNSYLVANIA 19456 US
    BNYMELLON111 SANDERS CREEK PARKWAY 2ND FLOOR

    2ND FLOOR EAST SYRACUSE
    BNYMELLON/RE BARCLAYS CAPITAL SECURITIES LTD.ONE WALL STREET NEW YORK

    NY NEW YORK 10286



    Broker NameBroker Address Broker NameBroker Address
     NY NEW YORK 13057 US  
    BNYMELLON/RE CACEIS BANK LUXEMBOURG500 Grant St.

    BNY Mellon Center PITTSBURGH

    PA PENNSYLVANIA

    15258
    BNYMELLON/RE CACEIS BANK, NETHERLANDS111 SANDERS CREEK PARKWAY

    EAST SYRACUSE NY NEW YORK 13057
    BNYMELLON/RE CHARLES STANLEY AND COMPANY, LIMITED111 SANDERS CREEK PARKWAY 2ND FLOOR

    2ND FLOOR EAST SYRACUSE NY NEW YORK

    13057 US
    BNYMELLON/RE ETF - ISHARES DTC/NSCC111 SANDERS CREEK PARKWAY

    EAST SYRACUSE NY NEW YORK 13057
    BNYMELLON/RE WINTERFLOOD SECURITIES LTD500 Grant St.

    BNY Mellon Center PITTSBURGH

    PA PENNSYLVANIA 15258
    BOFA4804 Deer Lake Drive East

    FL9-803-04-04- 4th

    floor JACKSONVILLE FL FLORIDA

    32246 US
    BOFA4804 Deer Lake Drive East

    FL9-803-04-04- 4th

    floor JACKSONVILLE FL FLORIDA

    32246 US
    BOFA SECURITIES INC4804 Deer Lake Drive East

    FL9-803-04-04- 4th

    floor JACKSONVILLE FL FLORIDA

    32246 US
    BROWN BROTHERS HARRIMAN & CO.140 BROADWAY ATTN: CORPORATE ACTIONS VAULT NEW YORK

    NY NEW YORK 10005 US
    BROWN BROTHERS HARRIMAN & CO./ETF140 BROADWAY NEW YORK

    NY NEW YORK 10005
    CALDWELL SECURITIES LTD./CDS**55 UNIVERSITY AVENUE

    SUITE 340 TORONTO ON ONTARIO

    M5J 2H7 CANADA
    CANACCORD GENUITY CORP.609 GRANVILLE ST VANCOUVER

    BC BRITISH COLUMBIA

    V7Y 1H2 CA CANADA
    CANTOR, FITZGERALD & CO.135 E 57TH ST 5TH FL

    NEW YORK

    NY NEW YORK 10041 US
    CDS CLEARING AND DEPOSITORY SERVICES INC.100 ADELAIDE STREET WEST TORONTO

    ON ONTARIO

    M5H 1S3 CA CANADA
    CETERA INVESTMENT SERVICES LLC400 FIRST STREET

    SOUTH, SUITE 300

    SUITE 300 ST. CLOUD
    CHARLES SCHWAB & CO., INC.211 MAIN STREET SAN FRANCISCO CA CALIFORNIA

    94105 US



    Broker NameBroker Address Broker NameBroker Address
     MN MINNESOTA 56302-0283 US  
    CI INVESTMENT SERVICES INC.199 BAY STREET

    SUITE 2600 TORONTO ON ONTARIO M5L 1E2 CA

    CANADA
    CIBC WORLD MARKETS INC./CDS**161 BAY STREET 10 FL

    TORONTO ON ONTARIO

    M5J 2S8 CA CANADA
    CITIBANK, N.A./ETF3800 CITIGROUP CENTER

    B2/2 TAMPA

    FL FLORIDA 33610
    CITIBANK, NATIONAL ASSOCIATION3800 CITIBANK CENTER TAMPA BLDG.B FIRST FLOOR ZONE 8 TAMPA

    FL FLORIDA 33610-9122 US
    CITIGROUP GLOBAL MARKETS, INC.580 CROSSPOINT PARKWAY GETZVILLE

    NY NEW YORK 14068 US
    CLEAR STREET LLC4 World Trade Center, 45th Floor

    150 Greenwich Street NEW YORK

    NY NEW YORK 10007
    CLEARSTREET IO55 BROADWAY

    (SUITE 2102) CORPORATE ACTIONS NEW YORK

    NEW YORK 10006 US
    COMMERCE BANK922 WALNUT STREET MAIL STOP TBTS-2 KANSAS CITY

    MO MISSOURI 64106 US
    COR CLEARING LLC9300 UNDERWOOD AVE

    SUITE 400 OMAHA

    NE NEBRASKA 68114 US
    Credential Securities Inc.800-1111 WEST GEORGIA STREET VANCOUVER

    BC BRITISH COLUMBIA

    V6E 4T6 CA CANADA
    CREST INTERNATIONAL NOMINEES LIMITED33 CANNON STREET LONDON EC4M 5SB GB

    UNITED KINGDO
    CURVATURE SECURITIES, LLC39 MAIN STREET CHATHAM

    NJ NEW JERSEY 07928 US
    D.A. DAVIDSON & CO.8 3RD STREET NORTH GREAT FALLS MT MONTANA

    59401 US
    DEPOSITO CENTRAL DE VALORES S.A., DEPOSITO DE

    VALORES
    AVENIDA APOQUINDO # 4001

    FLOOR 12, C.P.

    7550162, SANTIAGO CL CHILE



    Broker NameBroker Address Broker NameBroker Address
    DESJARDINS SECURITIES INC.1253 McGill College 10TH FLOOR MONTREAL QUEBEC

    H3B 2Y5 CA CANADA
    DEUTSCHE BANK AG NY/US CUSTODY1251 Avenue Of The Americas

    NEW YORK NY NEW YORK 10020
    DEUTSCHE BANK SECURITIES INC.60 WALL STREET

    9TH FLOOR NEW YORK NY NEW YORK 10005 US
    DRIVEWEALTH, LLC15 EXCHANGE PLACE

    10TH FLOOR JERSEY CITY

    NEW JERSEY 07302
    E*TRADE CLEARING LLCHARBORSIDE FINANCIAL CENTER

    501 PLAZA 11 JERSEY CITY

    NJ NEW JERSEY 07311 US
    EDWARD D. JONES & CO., L.P.12555 MANCHESTER ROAD

    ST. LOUIS

    MO MISSOURI 63131-3729 US
    EDWARD D. JONES & CO., L.P.201 PROGRESS PARKWAY MARYLAND HEIGHTS

    MO MISSOURI 63043 US
    FIDELITY CLEARING CANADA

    ULC/CDS**
    483 BAY ST. SOUTH TOWER TORONTO

    ON ONTARIO M5G2N7 CA CANADA
    FIFTH THIRD BANK5001 KINGSLEY DRIVE

    MAIL DROP 1MOB28 CINCINNATI

    OH OHIO 45227 US
    FOLIO INVESTMENTS, INC.8180 GREENSBORO DRIVE

    8TH FLOOR MCLEAN

    VA VIRGINIA 22102 US
    FUTU CLEARING INC.12750 Merit Drive

    SUITE 475 DALLAS TX TEXAS 75251
    GMP SECURITIES L.P.145 KING STREET

    WEST, SUITE 300 11TH FLOOR TORONTO

    ON ONTARIO

    MJ5 1J8 CA CANADA
    GOLDMAN, SACHS & CO. LLC222 SOUTH MAIN STREET

    Attn: Mandatory Corporate Actions SALT LAKE CITY UT UTAH

    84101 US
    HAYWOOD SECURITIES INC./CDS**200 BURRARD ST WATERFRONT CENTRE SUITE 700 VANCOUVER

    BC BRITISH COLUMBIA

    V6C 3L6 CANADA
    HILLTOP SECURITIES INC.1201 ELM ST.

    35TH FLOOR DALLAS

    TX TEXAS

    75270 US
    HRT FINANCIAL LLC150 GREENWICH STREET (ATTN: SETTLEMENT) FOUR WORLD TRADE

    CENTER



    Broker NameBroker Address Broker NameBroker Address
       57TH FLOOR NEW YORK NY NEW YORK

    10007 US
    HSBC BANK USA, NA/HSBC CUSTODY & CLEARING SERVICES FOR

    STOCK LOAN
    452 FIFTH AVENUE ATTN: HBUS CCS SETTS

    NEW YORK NY NEW YORK

    10018 US
    HSBC BANK USA, NATIONAL ASSOCIATION452 FIFTH AVENUE ATTN: HBUS CCS SETTS

    NEW YORK NEW YORK

    10018 US
    INTERACTIVE BROKERS LLC2 PICKWICK PLAZA

    2ND FLOOR GREENWICH

    CT CONNECTICUT

    06830 US
    J.P. MORGAN CHASE BANK NA/FBO BLACKROCK CTF1111 POLARIS PARKWAY COLUMBUS OH OHIO

    43240
    J.P. MORGAN CLEARING CORP.FOUR CHASE METROTECH CENTER

    3RD FLOOR BROOKLYN NY NEW YORK

    11201 US
    JANNEY MONTGOMERY SCOTT LLC1717 ARCH STREET

    17TH FLOOR PHILADELPHIA

    PA PENNSYLVANIA 19103 US
    JEFFERIES LLC101 HUDSON

    STREET, 11th Floor NEW JERSEY

    NJ NEW JERSEY 07302 US
    JPMORGAN CHASE BANK, NATIONAL ASSOCIATIONFOUR CHASE METROTECH CENTER

    3RD FLOOR BROOKLYN NY NEW YORK

    11201 US
    JPMORGAN CHASE BANK/EUROCLEAR BANKFOUR CHASE METROTECH CENTER

    3RD FLOOR BROOKLYN NY NEW YORK

    11245 US
    JPMORGAN CHASE BANK/IAFOUR CHASE METROTECH CENTER

    3RD FLOOR BROOKLYN NY NEW YORK

    11201 US
    KEYBANK NATIONAL ASSOCIATION4900 TIEDEMAN RD BROOKLYN

    OH OHIO 44144 US
    LAURENTIAN BANK SECURITIES INC.1981 MCGILL COLLEGE AVE. SUITE 100 MONTREAL QUEBEC

    H3A 3K3 CA CANADA
    LPL FINANCIAL LLC4707 EXECUTIVE DRIVE

    SAN DIEGO

    CA CALIFORNIA 92121 US
    MANUFACTURERS AND TRADERS TRUST COMPANYONE M&T PLAZA TRUST OPS 8TH FLOOR BUFFALO

    NY NEW YORK 14203 US



    Broker NameBroker Address Broker NameBroker Address
    MANULIFE SECURITIES INCORPORATED1235 NORTH SERVICE ROAD WEST OAKVILLE

    ON ONTARIO

    L6M 2W2 CA CANADA
    MARSCO INVESTMENT CORPORATION101 EISENHOWER PARKWAY ROSELAND

    NJ NEW JERSEY 07068 US
    MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED4804 Deer Lake Drive East

    FL9-803-04-04- 4th

    floor JACKSONVILLE FL FLORIDA

    32246 US
    MIRAE ASSET SECURITIES (USA) INC./STOCK LOAN CONDUIT ACCOUNT810 SEVENTH AVE

    37TH FLOOR NEW YORK

    NY NEW YORK 10019
    MIRAE ASSET SECURITIES (USA), INC.810 SEVENTH AVE

    37TH FLOOR NEW YORK NY NEW YORK 10019
    MITSUBISHI UFJ TRUST & BANKING CORPORATION, NEW YORK BRANCH280 PARK AVE

    39TH FL-WEST BLDG NEW YORK

    NY NEW YORK 10017
    Morgan Stanley1300 THAMES STREET

    THAMES STREET WHARF BALTIMORE

    MD MARYLAND 21231 US
    MORGAN STANLEY & CO. LLC1300 THAMES ST. BALTIMORE

    MD MARYLAND
    MORGAN STANLEY SMITH BARNEY LLC1 NEW YORK PLAZA

    39TH FLOOR NEW YORK

    NY NEW YORK 10004 US
    MURIEL SIEBERT & CO., INC.77 SUMMER STREET

    3RD FLOOR BOSTON MA

    MASSACHUSETTS 02210 US
    NATIONAL FINANCIAL SERVICES LLC499 WASHINGTON BOULEVARD

    5TH FLOOR JERSEY CITY NJ NEW JERSEY

    07310 US
    NBCN INC.1010 rue De La Gauchetière Mezzanine 100 MONTREAL QUEBEC

    H3B 5J2 CA CANADA
    NOMURA INTERNATIONAL TRUST COMPANY309 WEST 49TH STREET

    10TH FLOOR NEW YORK NY NEW YORK

    10019 US
    ODLUM BROWN LIMITED250 HOWE STREET

    SUITE 1100 VANCOUVER BC BRITISH COLUMBIA

    V6C 3R8 CA CANADA
    OPPENHEIMER & CO. INC.85 BROAD STREET NEW YORK

    NY NEW YORK 10004 US
    PERSHING LLC1 PERSHING PLAZA JERSEY CITY

    NJ NEW JERSEY 07399 US



    Broker NameBroker Address Broker NameBroker Address
    PHILLIP CAPITAL INC.141 W. JACKSON

    BLVD. SUITE 3050 CHICAGO

    IL ILLINOIS 60604 US
    PI FINANCIAL CORP.666 BURRARD ST

    SUITE 1900 VANCOUVER BC BRITISH COLUMBIA

    V6C 3N1 CA CANADA
    PNC BANK, NATIONAL ASSOCIATION4100 W 150TH STREET

    ASSET MOVEMENT TEAM 3RD FL, LOCATOR B7- YB17-03-03 CLEVELAND

    OH OHIO 44135 US
    PRINCIPAL BANK711 HIGH STREET DES MOINES

    IA IOWA 50392
    QUESTRADE INC./CDS**5650 YONGE ST.,

    Suite 1700 TORONTO ON ONTARIO M2M 4G3 CA

    CANADA
    Raymond James & Associates, Inc.880 CARILLON PKWY ST. PETERSBURG

    FL FLORIDA 33733-2749 US
    RAYMOND JAMES LTD.925 WEST GEORGIA STREET SUITE 2200 VANCOUVER



    BC BRITISH COLUMBIA V6C 3L2 CA

    CANADA
    RBC CAPITAL MARKETS, LLC60 SOUTH 6TH ST. MINNEAPOLIS MN MINNESOTA 55402 US
    RBC DOMINION SECURITIES INC21 COMMERCE COURT SOUTH 2ND FLOOR TORONTO

    ON ONTARIO

    M5L 1A7 CANADA
    RELIANCE TRUST COMPANY1100 ABERNATHY RD.

    500 NORTHPARK

    SUITE 400 ATLANTA GA GEORGIA

    30113 US
    RELIANCE TRUST COMPANY4900 W. BROWN DEER RD MILWAUKEE WI WISCONSIN 53223 USROBERT W. BAIRD & CO. INCORPORATED777 E WISCONSIN AVE

    9TH FLOOR MILWAUKEE WI WISCONSIN

    53202 US
    ROBINHOOD SECURITIES, LLC500 COLONIAL CENTER PARKWAY SUITE 100 LAKE MARY FL FLORIDA

    32746 US
    SAFRA SECURITIES LLC546 5TH AVENUE NEW YORK

    NY NEW YORK 10036 US



    Broker NameBroker Address Broker NameBroker Address
    SCOTIA CAPITAL (USA) INC.150 KING STREET W

    5TH FLOOR TORONTO ON ONTARIO M5H 1J9 CA

    CANADA
    SEI PRIVATE TRUST COMPANY1 FREEDOM VALLEY DRIVE

    OAKS

    PA PENNSYLVANIA 19456 US
    SEI PRIVATE TRUST COMPANY1 FREEDOM VALLEY DRIVE OAKS

    PA PENNSYLVANIA

    19456 US
    SG AMERICAS SECURITIES, LLC480 WASHINGTON BLVD.

    20TH FLOOR JERSEY CITY NJ NEW JERSEY

    07310 US
    SSB - BLACKROCK INSTITUTIONAL TRUST50 California Street San Francisco

    CA CALIFORNIA 94163
    SSB - TRUST CUSTODY30 ADELAIDE ST EAST

    SUITE 800 TORONTO ON ONTARIO M5C 3G6 CA

    CANADA
    SSB&T CO/CLIENT CUSTODY SERVICES1776 HERITAGE DRIVE

    NORTH QUINCY MA

    MASSACHUSETTS 02171
    STATE STREET BANK & TRUST CO16 WALL STREET

    5TH FLOOR NEW YORK

    NY NEW YORK 10005 US
    STATE STREET BANK & TRUST COMPANY / ISHARES EUROPE1776 HERITAGE DRIVE

    NORTH QUINCY MA MASSACHUSETTS

    02171
    STATE STREET BANK & TRUST/STATE STREET TOTALETF1776 Heritage Drive NORTH QUINCY MA MASSACHUSETTS 02717
    STATE STREET BANK AND TRUST COMPANY30 ADELAIDE ST EAST

    SUITE 800 TORONTO ON ONTARIO

    M5C 3G6 CA CANADA
    STIFEL, NICOLAUS & COMPANY, INCORPORATED501 N BROADWAY ST. LOUIS

    MO MISSOURI 63102 US
    STONEX FINANCIAL INC.2 PERIMETER PARK SOUTH SUITE 100 W BIRMINGHAM AL ALABAMA

    35243 US
    TD AMERITRADE CLEARING, INC.200 S 108TH AVE OMAHA

    NE NEBRASKA 68154 US
    TD WATERHOUSE CANADA INC ATTN: MANDATORY77 BLOOR STREET WEST

    3RD FLOOR TORONTO

    ON ONTARIO
    TEXAS TREASURY SAFEKEEPING TRUST COMPANY208 E 10TH ST AUSTIN

    TX TEXAS 78701 US



    Broker NameBroker Address Broker NameBroker Address
    CORPORATE ACTIONSM5S 1M2 CA CANADA  
    THE BANK OF NEW YORK MELLON500 GRANT STREET

    27TH FLOOR PITTSBURGH PA

    PENNSYLVANIA 15258 US
    THE HUNTINGTON NATIONAL BANK7 EASTON OVAL EA4E62 COLUMBUS

    OH OHIO 43209 US
    THE NORTHERN TRUST COMPANY333 South Wabash Ave, 32nd Floor Attn: Trade Securities Processing CHICAGO

    IL ILLINOIS 60603 US
    TRADESTATION SECURITIES, INC.120 RIVERSIDE PLAZA

    SUITE 1650 CHICAGO IL ILLINOIS 60606 US
    U.S. BANCORP INVESTMENTS, INC.60 LIVINGSTON AVE

    EP-MN-WN1B ST. PAUL

    MN MINNESOTA 55107-1419 US
    U.S. BANK N.A./ETF1555 N RIVER CENTER DRIVE MILWAUKEE WI WISCONSIN 53212
    U.S. BANK NATIONAL ASSOCIATION1555 NORTH RIVERCENTER DRIVE, SUITE 302

    SUITE 302 MILWAUKEE

    WI WISCONSIN 53212 US
    UBS AG480 WASHINGTON BLVD.

    12TH FLOOR JERSEY CITY NJ NEW JERSEY 07310 US
    UBS FINANCIAL SERVICES INC.1000 HARBOR BOULEVARD WEEHAWKEN NJ NEW JERSEY

    07086 US
    UBS SECURITIES LLC677 WASHINGTON BLVD

    STAMFORD

    CT CONNECTICUT 06901 US



    Broker NameBroker Address Broker NameBroker Address
    UMB BANK, NATIONAL ASSOCIATION928 GRAND BLVD KANSAS CITY MO MISSOURI 64106 USVANGUARD MARKETING CORPORATION100 VANGUARD BLVD MALVERN

    PA PENNSYLVANIA 19355 US
    VELOCITY CLEARING, LLC1301 Route 36

    Suite 109 (Attn: Chris Felicetti)

    HAZLET

    NEW JERSEY 7730 US
    VELOX CLEARING LLC2400 E. KATELLA AVENUE

    SUITE 725A ANAHEIM

    CA CALIFORNIA 92806 US
    VIRTU AMERICAS LLCONE LIBERTY PLAZA, 165 BROADWAY 5TH FLOOR NEW YORK NY NEW YORK

    10006 US
    VISION FINANCIAL MARKETS LLC4 HIGH RIDGE PARK SUITE 100 STAMFORD

    CT CONNECTICUT 06905 US
    WEDBUSH SECURITIES INC1000 WILSHIRE BLVD

    8TH FLOOR LOS ANGELES

    CA CALIFORNIA

    90017 US
    WEDBUSH SECURITIES INC.1000 WILSHIRE BLVD.

    LOS ANGELES CA CALIFORNIA 90017 US
    WELLS FARGO BANK, N.A./SIG733 MARQUETTE AVE 4TH FLOOR MAC N9306-04D MINNEAPOLIS

    MN MINNESOTA 55402 US
    WELLS FARGO CLEARING SERVICES LLC1 NORTH JEFFERSON MAIL CODE: H0006- 094

    ST. LOUIS

    MO MISSOURI 63103 US
    WELLS FARGO SECURITIES, LLC1525 WEST W T HARRIS BLVD CHARLOTTE NC NORTH CAROLINA

    28262 US
    WILSON-DAVIS & CO., INC.236 SOUTH MAIN STREET

    SALT LAKE CITY UT UTAH

    84101 US

    About Sorrento Therapeutics, Inc.

    Sorrento is a clinical and commercial stage biopharmaceutical company developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune disease and COVID-19. Sorrento's multimodal, multipronged approach to fighting cancer is made possible by its extensive immuno-oncology platforms, including key assets such as Abivertinib, next-generation tyrosine kinase inhibitors ("TKIs"), fully human antibodies ("G-MAB™ library"), immuno-cellular therapies ("DAR-T™"), antibody-drug conjugates ("ADCs"), and oncolytic virus ("Seprehvec™"). Sorrento is also developing potential antiviral therapies and vaccines against coronaviruses, including STI-1558, COVI-MSC™; and diagnostic test solutions, including COVIMARK™.

    Sorrento's commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a TRPV1 agonist, non-opioid pain management small molecule, resiniferatoxin ("RTX"), and SP-102 (10 mg, dexamethasone sodium phosphate viscous gel) (SEMDEXA™), a novel, viscous gel formulation of a widely used corticosteroid for epidural injections to treat lumbosacral radicular pain, or sciatica, and to commercialize ZTlido® (lidocaine topical system) 1.8% for the treatment of postherpetic neuralgia (PHN). RTX has been cleared for a Phase II trial for intractable pain associated with cancer and a Phase II trial in osteoarthritis patients. Positive final results from the Phase III Pivotal Trial C.L.E.A.R. Program for SEMDEXA™, its novel, non-opioid product for the treatment of lumbosacral radicular pain (sciatica), were announced in March 2022. ZTlido® was approved by the FDA on February 28, 2018.

    For more information visit www.sorrentotherapeutics.com

    Media and Investor Relations

    Contact: Brian Cooley

    Email: [email protected]

    Sorrento® and the Sorrento logo are registered trademarks of Sorrento Therapeutics, Inc.

    G-MAB™, DAR-T™, Seprehvec™, SOFUSA™, COVI-MSC™, COVIMARK™, Ovydso™ and Fujovee™ are trademarks of Sorrento Therapeutics, Inc.

    SEMDEXA™ (SP-102) is a trademark of Semnur Pharmaceuticals, Inc. A proprietary name review by the FDA is planned.

    ZTlido® is a registered trademark owned by Scilex Pharmaceuticals Inc. All other trademarks are the property of their respective owners.

    ©2023 Sorrento Therapeutics, Inc. All Rights Reserved.

    A PDF accompanying this release is available at http://ml.globenewswire.com/Resource/Download/3699e4bd-f545-4d16-ade8-fafa61627d7b



    Primary Logo

    Get the next $SRNE alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SRNE

    DatePrice TargetRatingAnalyst
    11/2/2022$5.00Overweight
    Cantor Fitzgerald
    8/9/2021$30.00 → $26.00Buy
    HC Wainwright & Co.
    More analyst ratings

    $SRNE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

      US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any shares of the Dividend Stock (including any such shares held by brokerage firms) may not be sold, transferred or otherwise disposed of.Scilex's transfer agent, Continental Stock Transfer & Trust Company, has been notified of the lock-up extension to April 14, 2025. PALO ALTO, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain manag

      1/31/25 9:00:00 AM ET
      $SCLX
      $SRNE
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Commercial Physical & Biological Resarch
    • Sorrento Therapeutics, Inc. Receives Court Approval for $75 Million Financing in Chapter 11 Case

      SAN DIEGO, Feb. 21, 2023 /PRNewswire/ -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, ", Sorrento", ))), a biopharmaceutical company dedicated to the development of life-saving therapeutics to treat cancer, intractable pain, and infectious disease, today announced that the U.S. Bankruptcy Court for the Southern District of Texas granted interim approval of Sorrento's $75 million debtor-in-possession financing from JMB Capital Partners, in connection with Sorrento's chapter 11 case, which was filed on February 13, 2023.  The financing will provide Sorrento with immediate liquidity so that it can continue operating its business as usual during its chapter 11 case. A hearing for final approval of

      2/21/23 5:57:00 PM ET
      $SCLX
      $SRNE
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Commercial Physical & Biological Resarch
    • Sorrento Posts Form 8937 to Supplement its Previously Issued "FAQ" Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, "Scilex")

      SAN DIEGO, Feb. 18, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento"))) today posted an IRS Form 8937 (the "Form 8937") to supplement its previously issued "Frequently Asked Questions" document under the "Investors" section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company ("Scilex") previously held by Sorrento. The Form 8937 has been filed with the Internal Revenue Service and Sorrento expects to send copies of the form in the coming days to brokerage firms, banks, dealers and similar organizations to whom a dividend confirmation had previously been distr

      2/18/23 8:37:04 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $SRNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Cantor Fitzgerald initiated coverage on Sorrento Therapeutics with a new price target

      Cantor Fitzgerald initiated coverage of Sorrento Therapeutics with a rating of Overweight and set a new price target of $5.00

      11/2/22 6:29:52 AM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • HC Wainwright & Co. reiterated coverage on Sorrento Therapeutics with a new price target

      HC Wainwright & Co. reiterated coverage of Sorrento Therapeutics with a rating of Buy and set a new price target of $26.00 from $30.00 previously

      8/9/21 6:25:18 AM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • B. Riley Securities initiated coverage on Sorrento Therapeutics with a new price target

      B. Riley Securities initiated coverage of Sorrento Therapeutics with a rating of Buy and set a new price target of $26.00

      1/29/21 7:40:31 AM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $SRNE
    Leadership Updates

    Live Leadership Updates

    See more
    • Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of Directors

      PALO ALTO, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Scilex Holding Company ("Scilex"), a nearly 100% (or over 99.9%) majority-owned subsidiary of Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento"))), a commercial biopharmaceutical company focused on developing and commercializing non-opioid therapies for patients with acute and chronic pain, announced today the appointment of the Honorable Tommy G. Thompson, former Secretary of the United States Department of Health and Human Services ("HHS") and former Governor of Wisconsin, to its Board of Directors. Governor Thompson's appointment is effective immediately. Governor Thompson currently serves as the Chief Executive Officer of Thomp

      7/5/22 2:04:42 PM ET
      $SRNE
      $VCKA
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
      Biotechnology: Biological Products (No Diagnostic Substances)
    • Sorrento Therapeutics, Inc. announces the appointment of the Honorable Tommy G. Thompson, as Covid-19 Special Consultant to Chairman and CEO Henry Ji

      SAN DIEGO, June 24, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento"))), a commercial and clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies and diagnostics, announced today the appointment of the Honorable Tommy G. Thompson, former Secretary of the United States Department of Health and Human Services ("HHS") and former Governor of Wisconsin, as Covid-19 special consultant to Sorrento's Chairman and CEO Henry Ji. Governor Thompson's appointment is effective immediately. Most recently, Thompson served as the President of the University of Wisconsin System from July 2020 through March 2022, one of the largest

      6/24/22 3:38:28 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Sorrento Therapeutics, Inc. Appoints Former Roche Executive Tammy Reilly to the Board of Directors

      SAN DIEGO, May 18, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc (NASDAQ:SRNE, "Sorrento"))), a commercial and clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies and diagnostics, announced today the appointment of former Roche Laboratories executive, Tammy Reilly, to Sorrento's board of directors. Ms. Reilly brings more than 30 years of life science, big pharma and operating leadership experience within healthcare therapeutics, consumer merchandising and healthcare diagnostic companies to Sorrento.  "Sorrento continues to strengthen its already experienced board of directors," said Henry Ji, Ph.D., Chairman and Chief Executive O

      5/18/22 9:00:00 AM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $SRNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Sorrento Therapeutics Inc. (Amendment)

      SC 13G/A - Sorrento Therapeutics, Inc. (0000850261) (Subject)

      3/10/23 11:21:36 AM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G filed by Sorrento Therapeutics Inc.

      SC 13G - Sorrento Therapeutics, Inc. (0000850261) (Subject)

      2/17/23 4:07:18 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form SC 13G/A filed by Sorrento Therapeutics Inc. (Amendment)

      SC 13G/A - Sorrento Therapeutics, Inc. (0000850261) (Subject)

      2/9/23 3:48:42 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $SRNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4 filed by Sorrento Therapeutics Inc.

      4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)

      3/20/23 7:52:53 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form 5: Janda Kim closing all direct ownership in the company

      5 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)

      2/6/23 9:10:05 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • SEC Form 4: Ji Henry exercised 500 in-the-money shares at a strike of $5.50

      4 - Sorrento Therapeutics, Inc. (0000850261) (Issuer)

      12/23/22 2:28:10 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care

    $SRNE
    Financials

    Live finance-specific insights

    See more
    • Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to April 14, 2025

      US Bankruptcy Court for the Southern District of Texas issued an order to extend the lock-up period on the Scilex Dividend Stock, previously distributed by Sorrento, to April 14, 2025.Accordingly, any shares of the Dividend Stock (including any such shares held by brokerage firms) may not be sold, transferred or otherwise disposed of.Scilex's transfer agent, Continental Stock Transfer & Trust Company, has been notified of the lock-up extension to April 14, 2025. PALO ALTO, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Scilex Holding Company (NASDAQ:SCLX, "Scilex" or "Company")), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain manag

      1/31/25 9:00:00 AM ET
      $SCLX
      $SRNE
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Commercial Physical & Biological Resarch
    • Sorrento Posts Form 8937 to Supplement its Previously Issued "FAQ" Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, "Scilex")

      SAN DIEGO, Feb. 18, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento"))) today posted an IRS Form 8937 (the "Form 8937") to supplement its previously issued "Frequently Asked Questions" document under the "Investors" section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company ("Scilex") previously held by Sorrento. The Form 8937 has been filed with the Internal Revenue Service and Sorrento expects to send copies of the form in the coming days to brokerage firms, banks, dealers and similar organizations to whom a dividend confirmation had previously been distr

      2/18/23 8:37:04 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Sorrento Issues Update to its Previously Issued "FAQ" Regarding the Dividend of Scilex Holding Company Common Stock (Nasdaq: SCLX, "Scilex")

      SAN DIEGO, Feb. 17, 2023 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ:SRNE, "Sorrento"))) today posted an update to its previously issued "Frequently Asked Questions" document under the "Investors" section of its website at www.sorrentotherapeutics.com regarding its recent dividend to Sorrento stockholders of shares of common stock of Scilex Holding Company previously held by Sorrento (the "Dividend Stock"). The update to the FAQs provides notice regarding the no lien code added on Scilex (NASDAQ:SCLX) common stock that was distributed as a dividend to Sorrento's stockholders and provides notice to brokerage firms, banks, dealers and similar organizations listed therein that a

      2/17/23 3:47:31 PM ET
      $SCLX
      $SRNE
      Biotechnology: Biological Products (No Diagnostic Substances)
      Health Care
      Biotechnology: Commercial Physical & Biological Resarch

    $SRNE
    SEC Filings

    See more
    • Sorrento Therapeutics Inc. filed SEC Form 8-K: Leadership Update, Other Events, Financial Statements and Exhibits

      8-K - Sorrento Therapeutics, Inc. (0000850261) (Filer)

      11/7/23 4:34:31 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Financial Statements and Exhibits

      8-K - Sorrento Therapeutics, Inc. (0000850261) (Filer)

      11/3/23 5:31:06 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care
    • Sorrento Therapeutics Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits

      8-K - Sorrento Therapeutics, Inc. (0000850261) (Filer)

      10/5/23 5:26:12 PM ET
      $SRNE
      Biotechnology: Commercial Physical & Biological Resarch
      Health Care